GBA1 and Parkinson disease: Regarding non-inhibitory chaperones, the NCGC607 compound was able to chaperone mutant GCase into lysosomes, restore GCase enzymatic activity and protein levels, and reduce abnormal substrate accumulation in both iPSC-derived macrophages and dopaminergic neurons from carriers of GBA mutations with or without parkinsonism [222].